Join Pr Robert MacLaren, Pr Dominik Fischer, and FundamentalVR’s immersive technologies expert Ashlie Leal on this edition of The Fundamentals series. They explore virtual reality’s function as an accelerant in the adoption of novel devices and therapies in gene therapy.
– Ways immersive technology can aid in gene therapy
– How pharmaceutical giant Novartis are leveraging a haptic-enabled gene therapy simulation in their training
– Expert insight into current and future gene therapy innovations